Advanced search
Publication Cover
Vascular Health and Risk Management Volume 11, 2015 - Issue
Submit an article Journal homepage
70
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Effectiveness and tolerability of second-line treatment with vildagliptin versus other oral drugs for type 2 diabetes in a real-world setting in the Middle East: results from the EDGE study

Charles Saab1 Department of Endocrinology and Metabolism, Sacre Coeur University Hospital, Baabda, Lebanon
,
Feryal A Al-Saber2 Endocrine Department, Bahrain Defence Force Hospital, Rifaa, Bahrain
,
Jihad Haddad3 Division of Endocrinology Department of Internal Medicine, Prince Hamaza Hospital, Amman, Jordan
,
Mahir Khalil Jallo4 Department of Internal Medicine, Gulf Medical University, Ajman, United Arab Emirates
,
Habib Steitieh5 New Mowasat Hospital, Safat, Kuwait
,
Giovanni Bader6 Novartis Pharma AG, Basel, Switzerland
&
Mohamed Ibrahim7 Novartis Pharma Services AG, Dubai, United Arab EmiratesCorrespondence[email protected]
 show all
Pages 149-155 | Published online: 24 Feb 2015

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.